1. Pharmaceuticals and Drug Development

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Written by Posted on Less than 0 min read

NEW HAVEN, Conn., May 14, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the Division of Neurology 1 within FDA’s Office of Neuroscience informed the Company that they are extending the PDUFA date for…

Member since

More from Admin

  1. Biology

Consensus paper: Carcinogenicity of gene therapies

Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here to read the article now. The researchers, led by James Wilson, MD, […]
Written by
  1. Biology

What role did fear play in Europe’s population growth?

[Vienna, August 26 2024] – Since the end of the last Ice Age, growth of human population was far from uniform, marked instead by periods of rapid expansion followed by sharp declines. The reasons behind these fluctuations remain only partially understood. Previous research by CSH scientists Peter Turchin, Daniel Kondor, and an international team of collaborators, demonstrated […]
Written by
  1. Biology

Researchers make breakthrough in fight against COVID-19

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at Rice, has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19. Credit: […]
Written by
  1. Biology

Work emails, calls on golf course worsen performance, study finds

Credit: Stellenbosch University to bre credited Journal International Journal of Performance Analysis in Sport DOI 10.1080/24748668.2024.2348285 Method of Research Data/statistical analysis Subject of Research People Article Title The effects of smartphone use during play on performance and enjoyment among recreational golfers Article Publication Date 12-Dec-2023 COI Statement No potential conflict of interest was reported by […]
Written by
  1. Biology

PITPβ promotes COPI vesicle fission through lipid transfer and membrane contact formation

Intracellular transport among organellar compartments occurs in two general ways: by membrane-bound carriers and membrane contacts. Specific circumstances that involve the coordination of these two modes of transport remain to be defined. By studying coat protein I (COPI) transport, we find that phosphatidylcholine with short acyl chains (sPC) is delivered through membrane contact from the […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Clinical Trial Finds Live Vaccinations Safe for Liver, Kidney Transplant Recipients

CINCINNATI, Oct. 16, 2023. Live vaccinations provided to children who previously received liver or kidney transplants were found to be safe and prompted an immune response to guard against several life-threatening conditions, according to a new study published Oct. 12, 2023, in JAMA Network Open. The study, based on data from 18 organ transplant centers, […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Patients after Cataract Surgery

SHANGHAI, Oct. 31, 2023. AffaMed Therapeutics (“AffaMed”), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychiatric disorders, announced positive top-line results from the Real-World Study conducted in the Boao Lecheng Pilot Zone in Hainan, China, to evaluate the […]
Written by
  1. Clinical

Novartis Phase III Data Confirm Sustained Efficacy and Long-Term Safety of Oral Remibrutinib in Chronic Spontaneous Urticaria

Basel, May 31, 2024 – Novartis today announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton’s tyrosine kinase (BTK) inhibitor, in chronic spontaneous urticaria (CSU)1. In the pivotal Phase III studies, REMIX-1 and REMIX-2, remibrutinib treatment showed significant symptom improvement early, which was sustained up to Week 52, […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

Bristol Myers Squibb Announces U.S. FDA Breakthrough Therapy Designation for Investigational LPA1 Antagonist for Progressive Pulmonary Fibrosis

PRINCETON, N.J. Oct 24, 2023 — Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist, for the treatment of progressive pulmonary fibrosis (PPF), a devastating, life-threatening illness. Currently, there is only one […]
Written by
  1. Clinical

Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease

CARLSBAD, Calif., July 18, 2024. Ionis Pharmaceuticals, Inc. announced today that it has completed enrollment in the pivotal trial of zilganersen (ION373), an investigational RNA-targeted medicine in development for the treatment of children and adults with a rare, progressive and ultimately fatal neurological disorder known as Alexander disease (AxD). The primary endpoint is percent change […]
Written by
  1. Clinical

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced dosing of the first patient in the multiple ascending dose (MAD) Part 2 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin (OXM) analog agonist that functions as a glucagon-like peptide-1 receptor (GLP1R) […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Viral ‘backbone’ underlies variation in rotavirus vaccine effectiveness

Researchers have shown that differences in the entire rotavirus genome — not just its two surface proteins — affect how well vaccines work, helping to explain why some strains are more likely to infect vaccinated individuals. The study, published today as a Reviewed Preprint in eLife, is described by the editors as an important paper. […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Zika uses human skin as ‘mosquito magnet’ to spread virus further

Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect and spread the disease further, new research shows. Zika transmission has been reported more than 90 countries as the spread of the Aedes aegypti mosquito that carries the virus, as well as dengue and chikungunya, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Early Pyrenean Neolithic groups applied species selection strategies to produce bone artifacts

A study led by researchers from the UAB and the CSIC has revealed that the earliest Neolithic groups to settle some 7,000 years ago in the Pyrenean site of Coro Trasito (Tella, Huesca) used species selection strategies to manufacture their tools made out of bone and chose deer for the projectile tips. The study, published […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

European potato genome decoded: Small gene pool with large differences

A research team has decoded the genome of historic potato cultivars and used this resource to develop an efficient method for analysis of hundreds of additional potato genomes. Potatoes are a staple food for over 1.3 billion people. But despite their importance for global food security, breeding successes have been modest. Some of the most […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Spliceosome: How cells avoid errors when manufacturing mRNA

A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed into mRNA precursors, is correctly assembled into mature mRNA. Splicing is a basic requirement for producing proteins that fulfill an organism’s vital functions. Faulty functioning of a spliceosome can lead to a variety of serious diseases. Researchers at […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Understanding how a red seaweed reduces methane emissions from cows

Methane is the second-largest contributor to climate warming after carbon dioxide, and so scientists have put a lot of attention toward addressing one of the top sources: methane emissions from livestock. In other words, cow burps and flatulence are bad for the planet. Farmers add various seaweeds to cow diets as a source of protein, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

AI tool maps out cell metabolism with precision

Understanding how cells process nutrients and produce energy — collectively known as metabolism — is essential in biology. However, analyzing the vast amounts of data on cellular processes to determine metabolic states is a complex task. Modern biology generates large datasets on various cellular activities. These “omics” datasets provide insights into different cellular functions, such […]
Written by
  1. Nonclinical

Pursuing a different calling: Embracing nonclinical career opportunities as a physician

Pursuing a Different Calling: Embracing Nonclinical Career Opportunities as a Physician As a physician, you have dedicated years of your life to the study and practice of medicine. You have honed your clinical skills, cared for countless patients, and made a significant impact on the lives of others. However, you may find yourself yearning for […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.